Transdermal Drug Delivery


Contents Overview

  • Structure and composition of skin

  • Advantages and disadvantages of transdermal delivery

  • Pathways of skin permeation

  • Laws governing drug permeation

  • Factors affecting drug bioavailability

  • Transdermal Drug Delivery Systems (TDDS)

  • Ways to improve transdermal drug delivery

  • Learning Outcomes

Dermal, Transcutaneous, and Transdermal

  • Objectives of Drug Therapy into and Through the Skin:

    • Delivery to Site of Action: Aim to deliver active drug to site within the skin.

    • Systemic Delivery: Deliver drugs to regions beyond the skin (e.g., musculature, joints).

    • Portal Entry: Use skin as entry point to systemic circulation for appropriately formulated drugs.

Why Skin as Systemic Administration Route?

Disadvantages:

  • Skin as a barrier; one of the most difficult barriers to penetrate.

  • Issues such as irritation and sensitization.

  • Drugs that induce tolerance may require a washout period.

Advantages:

  • Avoids first-pass metabolism, allowing drugs to maintain therapeutic levels in systemic circulation.

  • Reduces frequency of dosing required.

  • Improves patient compliance; drug input can be terminated by removing the patch.

Structure and Composition of Skin

  • Protective Organ:

    • Largest organ in the body.

    • Covers an area of roughly 1.65-1.85 m² for an average adult.

    • Accounts for approximately 16% of total body mass.

  • Layers of Skin:

    • Epidermis

    • Dermis

    • Hypodermis

Skin Structure Diagram

  • Key components: hair shaft, dermal papillae, sebaceous glands, sensory nerve fibers, etc.

  • Multiple layers within epidermis:

    • Stratum corneum, stratum lucidum, stratum granulosum, stratum spinosum, stratum basale.

  • Papillary Layer (Dermis): contains blood vessels and nerves.

  • Reticular Layer (Dermis): supports connective tissue, active glands, epithelium.

  • Hypodermis: provides insulation, mechanical cushion, not a significant barrier for drug delivery.

Epidermis

  • Keratinised Squamous Stratified Epithelium:

    • Primary function is protection, acting as a penetration barrier.

    • Varies in thickness across the body; thickest on soles of feet, thinnest on scrotum and eyelids.

    • Contains approximately 10-25% water content, modulated by disease, diet, and environment.

  • Stratum corneum as the main barrier, dense, lipophilic, and water-lacking.

Drug Permeation Pathways

Pathways Through the Skin

  1. Across the intact horny layer.

  2. Through the hair follicles (and associated sebaceous glands).

  3. Via the sweat glands.

    • Points 2 and 3 are termed transappendageal routes.

Routes Across Intact Skin

  • Transcellular Route:

    • Involves partitioning in and out of lipid and keratin domains.

    • Limited by the solubility of penetrant in both phases.

    • Important for depot formation (e.g. clotrimazole).

  • Intercellular Route:

    • Passage through the tortuous path represented by corneocytes.

    • Considered the main passage route, especially for small lipophilic molecules (e.g. nicotine).

Appendages as Access Points

  • Drug passage through hair follicles and sweat glands is limited due to opposing flow from glands and low surface coverage (0.1%).

    • Best suited for techniques such as iontophoresis and additional delivery methods.

Drug Absorption Through the Skin

  • Bioavailability Factors:

    • Rate and extent of absorption depend on permeation through stratum corneum via passive diffusion.

    • Fick's First Law of Diffusion:

    • J = (DK/h) Cv = Kp Cv

    • Where:

      • J = flux

      • D = diffusivity in SC

      • K = SC/formulation partition coefficient

      • h = membrane thickness

      • CvC_v = concentration of substance in vehicle.

Factors Affecting Bioavailability

Physicochemical Factors:

  • Drug concentration, partition coefficient, degree of ionisation, lipophilicity, molecular weight, particle size, solubility in excipients, viscosity.

Physiological Factors:

  • Skin condition (intact, injured, inflammatory changes), age, gender variations, cutaneous metabolism, and blood flow.

Ideal Molecular Properties for Drug Penetration

  • Low molecular mass (preferably < 600 Da) with high diffusion coefficient.

  • Adequate oil-water solubility to maintain high concentration gradient.

  • Balanced partition coefficient for optimal penetration properties.

  • Low melting point correlating with ideal solubility.

Transdermal Delivery Systems (TDDS)

Types of Patches

  • Adhesive patches

  • Layered patches

  • Reservoir patches

    • Common exterior features: impermeable backing, peel strip for application.

Rate Control Mechanisms

  • Rate is controlled by a polymeric membrane.

  • Reservoir patches characterized as follows:

    • Enclosed reservoir for drug.

    • Polymeric drug-release membrane.

    • Initial burst effect from small drug amounts in adhesive layer.

Penetration Enhancers

  • Effective enhancers should be:

    • Pharmacologically inert, non-toxic, non-irritating.

    • Skin recovery after removal should be quick.

    • Compatible with the drug and excipients.

    • Good solvent, cosmetically acceptable, cost-effective.

  • Examples include: water, fatty acids, alcohols, surfactants, and urea.

Microneedle Arrays

  • Developed to create microscopic punctures to improve drug delivery.

  • Needles range from 100 to 1000 µm, designed to penetrate without reaching blood vessels or nerves.

  • They can be hollow, allowing for both delivery and sample withdrawal.

Application and Advantages of Microneedles

  • Large surface exposure with minimal invasiveness, suited for self-administration.

  • Enable controlled delivery and monitoring through simultaneous drug delivery and sample retrieval.

Conclusion

  • Ongoing research is essential for optimizing transdermal formulations and systems.

  • Understanding permeability, drug properties, and delivery mechanisms remains crucial for successful transdermal therapies.